{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T16:39:42Z","timestamp":1792773582637,"version":"4.5.0"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","diabetesresearchclinicalpractice.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Research and Clinical Practice"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.diabres.2026.113623","type":"journal-article","created":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T15:39:06Z","timestamp":1792769946000},"page":"113623","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Sodium-Glucose Cotransporter-2 inhibitor use during or after acute kidney injury and the risk of major adverse kidney events and Mortality: A systematic review and Meta-Analysis"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-1980-7749","authenticated-orcid":false,"given":"Sama","family":"Abdel-Rahman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Marji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullah","family":"Nasir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-6649-1013","authenticated-orcid":false,"given":"Mahmoud","family":"Jarrar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-0701-1367","authenticated-orcid":false,"given":"Anas Khodr","family":"Abdo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Mammadzada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmut","family":"Altindal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian","family":"Covic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1297-0675","authenticated-orcid":false,"given":"Mehmet","family":"Kanbay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.diabres.2026.113623_b0005","doi-asserted-by":"crossref","first-page":"c179","DOI":"10.1159\/000339789","article-title":"KDIGO clinical practice guidelines for acute kidney injury","volume":"120","author":"Khwaja","year":"2012","journal-title":"Nephron Clin Pract"},{"key":"10.1016\/j.diabres.2026.113623_b0010","unstructured":"International Diabetes Federation. IDF Diabetes Atlas, 11th edn. Brussels, Belgium: 2025. Available from: https:\/\/diabetesatlas.org."},{"issue":"1","key":"10.1016\/j.diabres.2026.113623_b0015","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/s41572-021-00284-z","article-title":"Acute kidney injury","volume":"7","author":"Kellum","year":"2021","journal-title":"Nat Rev Dis Primers"},{"issue":"1","key":"10.1016\/j.diabres.2026.113623_b0020","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.kint.2018.08.036","article-title":"Long-term risk of adverse outcomes after acute kidney injury: a systematic review and meta-analysis of cohort studies using consensus definitions of exposure","volume":"95","author":"See","year":"2019","journal-title":"Kidney Int"},{"issue":"5","key":"10.1016\/j.diabres.2026.113623_b0025","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1038\/nrneph.2015.3","article-title":"Mechanisms of maladaptive repair after AKI leading to accelerated kidney ageing and CKD","volume":"11","author":"Ferenbach","year":"2015","journal-title":"Nat Rev Nephrol"},{"issue":"2","key":"10.1016\/j.diabres.2026.113623_b0030","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1056\/NEJMoa2204233","article-title":"Empagliflozin in patients with Chronic Kidney Disease","volume":"388","author":"The","year":"2023","journal-title":"N Engl J Med"},{"issue":"21","key":"10.1016\/j.diabres.2026.113623_b0035","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1056\/NEJMoa1911303","article-title":"Dapagliflozin in patients with Heart failure and Reduced Ejection Fraction","volume":"381","author":"McMurray","year":"2019","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.diabres.2026.113623_b0040","doi-asserted-by":"crossref","DOI":"10.5527\/wjn.v14.i4.112302","article-title":"Sodium-glucose cotransporter-2 inhibitors beyond glycemic control: their role in acute kidney injury recovery","volume":"14","author":"Ahsan","year":"2025","journal-title":"World J Nephrol"},{"key":"10.1016\/j.diabres.2026.113623_b0045","article-title":"Beyond glycemic control: the cardiac and hepatic benefits of SGLT2 and DPP-4 inhibitors in mitigating chronic cadmium-induced inflammation, oxidative\/nitrative stress, apoptosis and fibrosis","volume":"16","author":"Hassan","year":"2025","journal-title":"Front Physiol"},{"issue":"3","key":"10.1016\/j.diabres.2026.113623_b0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.xkme.2026.101248","article-title":"Sodium-Glucose Cotransporter-2 Inhibitors and Acute Kidney Injury Risk: a Systematic Review and Meta-Analysis of Randomized Trials","volume":"8","author":"Chiang","year":"2026","journal-title":"Kidney Med"},{"issue":"18","key":"10.1016\/j.diabres.2026.113623_b0055","doi-asserted-by":"crossref","DOI":"10.3390\/jcm14186365","article-title":"Long-Term Cardiorenal Benefits of Sodium-Glucose Cotransporter-2 Inhibitors in patients with Type 2 Diabetes Mellitus: a Real-World Single-Center Experience","volume":"14","author":"Agha","year":"2025","journal-title":"J Clin Med"},{"issue":"10","key":"10.1016\/j.diabres.2026.113623_b0060","doi-asserted-by":"crossref","DOI":"10.3390\/jcm14103349","article-title":"Renal and Safety Outcomes of SGLT2 Inhibitors in patients with Type 2 Diabetes: a Nationwide Observational Cohort Study","volume":"14","author":"Chang","year":"2025","journal-title":"J Clin Med"},{"issue":"3","key":"10.1016\/j.diabres.2026.113623_b0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.xkme.2024.100963","article-title":"Sodium-Glucose Cotransporter-2 Inhibitors and Prevention of adverse Kidney Outcomes in Type 2 Diabetes: a Clinical Multiethnic Asian Cohort","volume":"7","author":"Feng","year":"2025","journal-title":"Kidney Med"},{"issue":"11","key":"10.1016\/j.diabres.2026.113623_b0070","doi-asserted-by":"crossref","DOI":"10.1111\/eci.70080","article-title":"Adverse kidney events with initiation of SGLT2 inhibitors versus DPP4 inhibitors in diabetic people with a history of acute kidney injury","volume":"55","author":"Kao","year":"2025","journal-title":"Eur J Clin Invest"},{"issue":"3","key":"10.1016\/j.diabres.2026.113623_b0075","doi-asserted-by":"crossref","first-page":"381","DOI":"10.7326\/M22-2904","article-title":"Diabetes Management in Chronic Kidney Disease: Synopsis of the KDIGO 2022 Clinical Practice Guideline Update","volume":"176","author":"Navaneethan","year":"2023","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1016\/j.diabres.2026.113623_b0080","doi-asserted-by":"crossref","first-page":"335","DOI":"10.34067\/KID.0000000000000375","article-title":"Kidney Outcomes with Sodium-Glucose Cotransporter-2 Inhibitor Initiation after AKI among Veterans with Diabetic Kidney Disease","volume":"5","author":"Murphy","year":"2024","journal-title":"Kidney 360"},{"issue":"3","key":"10.1016\/j.diabres.2026.113623_b0085","article-title":"SGLT2 Inhibitors and Long-Term Outcomes after AKI","volume":"11","author":"Wannakittirat","year":"2026","journal-title":"Kidney Int Rep"},{"issue":"10","key":"10.1016\/j.diabres.2026.113623_b0090","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.34067\/KID.0000000000000250","article-title":"Outcomes Associated with Sodium-Glucose Cotransporter-2 Inhibitor Use in Acute Heart failure Hospitalizations Complicated by AKI","volume":"4","author":"Aklilu","year":"2023","journal-title":"Kidney 360"},{"issue":"10S","key":"10.1016\/j.diabres.2026.113623_b0095","doi-asserted-by":"crossref","first-page":"p","DOI":"10.1681\/ASN.2025mck1neet","article-title":"SGLT2 Inhibitors and GLP-1 Receptor Agonists and the risk for adverse Outcomes after AKI or Acute Kidney Disease: Systematic Review and Meta-Analysis: FR-PO0074","volume":"36","author":"Barreto","year":"2025","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"10.1016\/j.diabres.2026.113623_b0100","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1681\/ASN.2020030323","article-title":"The Relationship between AKI and CKD in patients with Type 2 Diabetes: an Observational Cohort Study","volume":"32","author":"Hapca","year":"2021","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.diabres.2026.113623_b0105","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"issue":"4","key":"10.1016\/j.diabres.2026.113623_b0110","doi-asserted-by":"crossref","first-page":"268","DOI":"10.7326\/M16-2607","article-title":"Sensitivity Analysis in Observational Research: introducing the E-Value","volume":"167","author":"VanderWeele","year":"2017","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.diabres.2026.113623_b0115","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.50050","article-title":"Sodium-Glucose Cotransport Protein 2 Inhibitors in patients with Type 2 Diabetes and Acute Kidney Disease","volume":"7","author":"Pan","year":"2024","journal-title":"JAMA Netw Open"},{"issue":"1","key":"10.1016\/j.diabres.2026.113623_b0120","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.kint.2024.03.026","article-title":"A cohort study of sodium-glucose cotransporter-2 inhibitors after acute kidney injury among Veterans with diabetic kidney disease","volume":"106","author":"Murphy","year":"2024","journal-title":"Kidney Int"},{"key":"10.1016\/j.diabres.2026.113623_b0125","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1356991","article-title":"SGLT2i treatment during AKI and its association with major adverse kidney events","volume":"15","author":"Alcantar-Vallin","year":"2024","journal-title":"Front Pharmacol"},{"issue":"2","key":"10.1016\/j.diabres.2026.113623_b0130","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1093\/ndt\/gfaf132","article-title":"SGLT2 inhibitors and acute kidney injury","volume":"41","author":"Nakao","year":"2026","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"10.1016\/j.diabres.2026.113623_b0135","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.kint.2019.09.013","article-title":"The renal hemodynamic effects of the SGLT2 inhibitor dapagliflozin are caused by post-glomerular vasodilatation rather than pre-glomerular vasoconstriction in metformin-treated patients with type 2 diabetes in the randomized, double-blind RED trial","volume":"97","author":"van Bommel","year":"2020","journal-title":"Kidney Int"},{"issue":"6","key":"10.1016\/j.diabres.2026.113623_b0140","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.173675","article-title":"Transient inhibition of sodium-glucose cotransporter 2 after ischemia\/reperfusion injury ameliorates chronic kidney disease","volume":"9","author":"Martinez-Rojas","year":"2024","journal-title":"JCI Insight"}],"container-title":["Diabetes Research and Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822726005437?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822726005437?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T15:39:11Z","timestamp":1792769951000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168822726005437"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":28,"alternative-id":["S0168822726005437"],"URL":"https:\/\/doi.org\/10.1016\/j.diabres.2026.113623","relation":{},"ISSN":["0168-8227"],"issn-type":[{"value":"0168-8227","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sodium-Glucose Cotransporter-2 inhibitor use during or after acute kidney injury and the risk of major adverse kidney events and Mortality: A systematic review and Meta-Analysis","name":"articletitle","label":"Article Title"},{"value":"Diabetes Research and Clinical Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabres.2026.113623","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"113623"}}